Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
CD Protein Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
8
16
24
32
40
48
56
64
72
80
Opdivo
(nivolumab) / BMS
Imfinzi
(durvalumab) / AstraZeneca
Ibrance
(palbociclib) / Pfizer
Tevimbra
(tislelizumab-jsgr) / BeiGene
Jemperli
(dostarlimab-gxly) / GSK
Verzenio
(abemaciclib) / Eli Lilly
socazolimab
(STI-A1014) / Sorrento
ezabenlimab
(BI 754091) / Boehringer Ingelheim
